Clinical Cancer Research The Science of Cancer Health Disparities Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fackler, M. J.
Right arrow Articles by Sukumar, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fackler, M. J.
Right arrow Articles by Sukumar, S.
Clinical Cancer Research Vol. 12, 3306-3310, June 1, 2006
© 2006 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

Quantitative Multiplex Methylation-Specific PCR Analysis Doubles Detection of Tumor Cells in Breast Ductal Fluid

Mary Jo Fackler1, Kara Malone1, Zhe Zhang1, Eric Schilling3, Elizabeth Garrett-Mayer1, Theresa Swift-Scanlan1, Julie Lange2, Ritu Nayar4, Nancy E. Davidson1, Seema A. Khan3 and Saraswati Sukumar1

Authors' Affiliations: Departments of 1 Oncology and 2 Surgery, Johns Hopkins University School of Medicine, Baltimore Maryland and Departments of 3 Surgery and 4 Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois

Requests for reprints: Saraswati Sukumar, Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Room 410, Bunting/Blaustein Building, 1650 Orleans Street, Baltimore, MD 21231-1000. Phone: 410-614-2479; Fax: 410-614-4073; E-mail: saras{at}jhmi.edu.

Purpose: The challenges of cytology for accurate diagnosis of breast cancer are well recognized. We previously showed that normal and tumor tissue can be distinguished using a technique called quantitative multiplex methylation-specific PCR (QM-MSP). We hypothesized that quantitative analysis of methylated genes will provide enhanced detection of cancer cells present in cytologic specimens.

Experimental Design: QM-MSP was done on ductal lavage cells from a set of 37 ductal lavage samples from women undergoing mastectomy (27 with cancer and 3 without). Duct histology information was available for each lavaged duct. QM-MSP data was assessed by measuring cumulative methylation index and by receiver operating characteristic threshold analysis. To determine the baseline level of methylation for each gene in this population, cells from 60 ducts of women at high risk of developing breast cancer were analyzed.

Results: QM-MSP findings on a panel of nine genes were correlated to duct histology and ductal lavage cytology. Cytology detected cancer in 33% (7 of 21 ducts) with a specificity of 99% (92 of 93). QM-MSP detected cancer as calculated by cumulative methylation index with a sensitivity of 62% (13 of 21) and specificity of 82% (62 of 76) and by receiver operating characteristic threshold analysis with a sensitivity of 71% (15 of 21) and specificity of 83% (63 of 76).

Conclusions: Compared with cytology, QM-MSP doubled the sensitivity of detection of cancer. This study provides proof of principle by showing the advantages of using methylation analyses to query cytologic specimens and indicates its potential use in diagnosis and in stratifying risk.




This article has been cited by other articles:


Home page
Ann OncolHome page
K. P. M. Suijkerbuijk, M. J. Fackler, S. Sukumar, C. H. van Gils, T. van Laar, E. van der Wall, M. Vooijs, and P. J. van Diest
Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer
Ann. Onc., July 22, 2008; (2008) mdn409v1.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. M. Wu, M. J. Fackler, M. K. Halushka, D. W. Molavi, M. E. Taylor, W. W. Teo, C. Griffin, J. Fetting, N. E. Davidson, A. M. De Marzo, et al.
Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal Metastases
Clin. Cancer Res., April 1, 2008; 14(7): 1938 - 1946.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. Esteller
Epigenetics in Cancer
N. Engl. J. Med., March 13, 2008; 358(11): 1148 - 1159.
[Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
A. A. Melnikov, D. M. Scholtens, E. L. Wiley, S. A. Khan, and V. V. Levenson
Array-Based Multiplex Analysis of DNA Methylation in Breast Cancer Tissues
J. Mol. Diagn., January 1, 2008; 10(1): 93 - 101.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. M. Euhus, D. Bu, R. Ashfaq, X.-J. Xie, A. Bian, A. M. Leitch, and C. M. Lewis
Atypia and DNA Methylation in Nipple Duct Lavage in Relation to Predicted Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1812 - 1821.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. J. Fabian
Is There a Future for Ductal Lavage?
Clin. Cancer Res., August 15, 2007; 13(16): 4655 - 4656.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Visvanathan, S. Sukumar, and N. E. Davidson
Epigenetic Biomarkers and Breast Cancer: Cause for Optimism.
Clin. Cancer Res., November 15, 2006; 12(22): 6591 - 6593.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.